Ionis Pharmaceuticals | IONS - Gross Profit On Sales

Stock Price
81.15
Daily Change
0.55 0.68%
Monthly
-0.94%
Yearly
144.50%
Q1 Forecast
80.57

Ionis Pharmaceuticals reported $195M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agios Pharmaceuticals USD 18.09M 6.89M Dec/2025
Alnylam Pharmaceuticals USD 829.31M 219.56M Dec/2025
Arrowhead Research USD 256.47M 228.7M Sep/2025
Astellas Pharma JPY 456.81B 38.02B Dec/2025
BioCryst Pharmaceuticals USD -88.88M 202.74M Dec/2024
BioMarin Pharmaceutical USD 713.01M 81.81M Dec/2025
Celltrion KRW 626.11B 81.75B Sep/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Exelixis USD 572.18M 7M Dec/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Knight Therapeutics CAD 44.83M 9.96M Jun/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Moderna USD 226M 583M Dec/2025
Nektar Therapeutics USD 13.75M 650K Jun/2024
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Neurocrine Biosciences USD 787.9M 7M Dec/2025
Novartis USD 10.82B 695M Sep/2025
Omeros USD -33.16M 18.52M Jun/2024
OPKO Health USD 46.89M 27.83M Sep/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Pharma Mar EUR 33.36M 20.25M Sep/2025
PTC Therapeutics USD 148.38M 39.31M Dec/2025
Qiagen NV USD 325.27M 19.53M Dec/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sarepta Therapeutics USD 43.55M 204.36M Dec/2025
Sartorius EUR 393.2M 23M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 67.63M 15.62M Mar/2025
Ultragenyx Pharmaceutical USD 178M 46.06M Dec/2025
Vertex Pharmaceuticals USD 2.72B 62.4M Dec/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025